Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

(2019) Sophie Testa et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk

(2019) Alex C Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

(2019) James D. Douketis et al.   JAMA Internal Medicine

Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants

(2018) S. Testa et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

(2018) Terese T. Horlocker et al.   REGIONAL ANESTHESIA AND PAIN MEDICINE

Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial

(2018) James Douketis et al.   THROMBOSIS AND HAEMOSTASIS

Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study

(2017) Anne Godier et al.   EUROPEAN HEART JOURNAL

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

(2017) Alex Spyropoulos et al.   THROMBOSIS AND HAEMOSTASIS

Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population‐Based Study

(2017) Amy Y. X. Yu et al.   Journal of the American Heart Association

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures

(2016) A. Tripodi   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures: comment

(2016) A. C. Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery

(2016) A. C. Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban

(2015) Charles E. Frost et al.   CLINICAL PHARMACOKINETICS

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

(2015) James D. Douketis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations

(2015) Anne Godier et al.   THROMBOSIS RESEARCH

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

(2014) D. Garcia et al.   BLOOD

Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

(2014) Matthew W. Sherwood et al.   CIRCULATION

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

(2013) Gilles Pernod et al.   Archives of Cardiovascular Diseases

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

(2013) Vijay V. Upreti et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

How I treat anticoagulated patients undergoing an elective procedure or surgery

(2012) A. C. Spyropoulos et al.   BLOOD

Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists

(2012) Deborah Siegal et al.   CIRCULATION

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin

(2012) Jeff S. Healey et al.   CIRCULATION

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery

(2009) Wolfgang Mueck et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects

(2009) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS